Thermo Fisher Scientific (TMO) News: Latest Market and Industry Updates

677.37
12.8300
1.86 %
Daily range
Weekly range
  • Oksana Koneva
  • 05.10.2026
McKesson and CD&R near Option Care Health buyout
Healthcare dealmaking in the U.S. is continuing to target service providers tied to higher-acuity care outside hospitals. McKesson and Clayton Dubilier & Rice are nearing an agreement to acquire ...
  • Artem Shendetskii
  • 23.09.2026
Pollen Street explores sale options amid asset management consolidation
Pressure to build scale is intensifying across asset management as mid-sized firms face tougher competition for investor capital and higher regulatory and operating costs. Against that backdrop, ...
  • Anton Kharitonov
  • 15.09.2026
TMO surges as new Heratherm environmental chambers launch
Thermo Fisher Scientific (TMO) stock is trading at $637.82, marking a rise of 3.93% for the day. The price sits comfortably above its key moving averages, reflecting ...
  • Ciaran Ryan
  • 15.09.2026
Bluerock fund discount to NAV widens as Saba pushes for board and manager changes
Months after its conversion from an interval fund to a listed vehicle, the Bluerock Private Real Estate Fund is still trading far below its stated net asset value instead of narrowing the gap. The ...
  • Hanna Syniavska
  • 10.09.2026
Franklin Templeton extends growth push as Western Asset crisis recedes
After a damaging period of client withdrawals tied to turmoil at Western Asset Management, Franklin Templeton is regaining momentum across its broader business. The asset manager says positive ...
  • Olga Shendetskaya
  • 08.09.2026
Cerberus nears Goodwin defence unit acquisition in potential £1bn deal
Goodwin is nearing a potential sale of its defence business as private equity interest builds around military suppliers with naval exposure in the UK and the U.S. The proposed transaction values ...
  • Ciaran Ryan
  • 17.08.2026
General Atlantic revives IPO effort with JPMorgan lead role
Private equity-backed listings are regaining momentum as investor appetite improves in the U.S. market. General Atlantic is now moving ahead again with an initial public offering after shelving ...
  • Ashutosh Sureka
  • 03.08.2026
KKR to take Integer Holdings private in $5.7 billion healthcare deal
Private equity activity in healthcare continues as KKR agrees to acquire medical-device outsourcing company Integer Holdings in an all-cash transaction valued at about $5.7 billion. The buyout ...
  • Ashutosh Sureka
  • 02.08.2026
UK-listed companies draw unsolicited takeover bids from overseas buyers
A sharp rise in unsolicited takeover approaches is reshaping dealmaking around London-listed companies as foreign acquirers test shareholders’ willingness to back premium offers. In the second ...
  • Ciaran Ryan
  • 23.07.2026
3i Group reports higher FY2027 first-quarter NAV as Action sales and EBITDA grow
3i Group is starting FY2027 with asset growth supported by continued momentum at discount retailer Action and steady performance across its broader portfolio. Net asset value per share rises to ...
  • Ciaran Ryan
  • 21.07.2026
U.S. Treasury warns hedge funds over tax alpha strategies as AMG shares fall
U.S. officials are stepping up scrutiny of fast-growing hedge fund strategies that aim to cut investors' tax bills through tax-loss harvesting and leveraged trading. The warning hits a niche that ...
  • Ciaran Ryan
  • 03.07.2026
UK programme expands employer drive to keep workers in jobs despite ill-health
A UK effort to reduce workforce exits linked to poor health reaches a new milestone as nearly 200 workplaces sign up as "Vanguards". The programme is part of a broader push to address long-term ...
  • Ashutosh Sureka
  • 30.06.2026
Oppenheimer cuts ratings on U.S. investment banks, favors alternative asset managers
U.S. financial stocks are diverging in premarket trading after Oppenheimer took the unusual step of lowering its stance on several top investment banks. The brokerage says strong operating ...
  • Sholanke Dele
  • 19.06.2026
Thermo Fisher Scientific stock price forecast: $467.66 resistance as TMO trades flat
Thermo Fisher Scientific (TMO) stock is trading at $466.10, up 0.95% on the day. The price sits below its key moving averages, with moderate volatility as the session ...
  • Ashutosh Sureka
  • 09.06.2026
Ancora pushes Ashland to pursue sale as activist stake raises takeover pressure
Pressure is building on Ashland after a sharp decline in its share price and weaker recent earnings revived questions about the specialty chemicals group's standalone value. Ancora Alternatives ...
  • Dan Blystone
  • 02.06.2026
Senate Democrats press Labor Department to drop 401(k) alternative assets plan
A dispute over retirement investment rules is intensifying as senior congressional Democrats push back against a Labor Department proposal affecting U.S. workers' savings. The lawmakers say ...
  • Ciaran Ryan
  • 02.06.2026
Mobia Medical gains Goldman Sachs buy rating as bank sees 130% upside
Fresh from its Nasdaq debut in early May, Mobia Medical is drawing bullish attention as it targets a relatively underserved segment of stroke recovery care. Goldman Sachs starts coverage of the ...